Aspartame, Chronic Kidney Insufficiency and Ocimum gratissimum Extract

R. S. Ajani, Onyinyechukwu Maureen Agagwu
{"title":"Aspartame, Chronic Kidney Insufficiency and Ocimum gratissimum Extract","authors":"R. S. Ajani, Onyinyechukwu Maureen Agagwu","doi":"10.9734/jamps/2023/v25i12659","DOIUrl":null,"url":null,"abstract":"Objective: The paired human kidneys are retroperitoneal organs responsible for the maintenance of the internal meliu of the human body. Chronic kidney disease is major cause of morbidity and mortality globally. Nutrition and life style are two main factors in the aetiopathogenesis of chronic kidney disease. Aspartame is a non-nutritive sweetener commonly consumed worldwide. Ocimum gratissimum is a naturally growing plant with some medicinal benefits. This study investigated if oral administration of aspartame could induce renal insufficiency in rat and the plausible ameliorative role of O. gratissimum extract.\nMethodology: Fifty animals allotted to four groups were used for the study. The control group (CN) had normal feed. The Aspartame group (Asp) had 250 mg/kg/day of aspartame for 28 days. The Aspartame low dose O. gratissimum extract group (ALO) had 250 mg/kg/day of aspartame for 28 days followed by once daily dose of the extract at 100 mg/kg for 28 days. For the Aspartame high dose O. gratissimum extract group (AHO); aspartame was administered at 250 mg/kg once daily for 28 days followed by another 28-day daily administration of the plant extract at 200mg/kg. Both aspartame and plant extract were administered orally. Periodically, blood samples were collected for biochemical analyses and kidneys harvested for histopathological examination.\nResults: The biochemical parameters of renal insufficiency were significantly pronounced in the Asp group but not in the AHO. Oxidative stress was pronounced in the Asp and ALO but not in group AHO at day 57. Histopathological examination of the kidney obtained from the Aspartame group revealed destruction of glomeruli.\nChronic administration of aspartame in rat caused sustained renal insufficiency which was ameliorated by prolonged administration of high dose of Ocimum gratissimum extract. Thus O. gratissimum extract is beneficial to aspartame induced renal toxicity in a dose dependent manner.","PeriodicalId":14903,"journal":{"name":"Journal of Advances in Medical and Pharmaceutical Sciences","volume":"21 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Advances in Medical and Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9734/jamps/2023/v25i12659","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: The paired human kidneys are retroperitoneal organs responsible for the maintenance of the internal meliu of the human body. Chronic kidney disease is major cause of morbidity and mortality globally. Nutrition and life style are two main factors in the aetiopathogenesis of chronic kidney disease. Aspartame is a non-nutritive sweetener commonly consumed worldwide. Ocimum gratissimum is a naturally growing plant with some medicinal benefits. This study investigated if oral administration of aspartame could induce renal insufficiency in rat and the plausible ameliorative role of O. gratissimum extract. Methodology: Fifty animals allotted to four groups were used for the study. The control group (CN) had normal feed. The Aspartame group (Asp) had 250 mg/kg/day of aspartame for 28 days. The Aspartame low dose O. gratissimum extract group (ALO) had 250 mg/kg/day of aspartame for 28 days followed by once daily dose of the extract at 100 mg/kg for 28 days. For the Aspartame high dose O. gratissimum extract group (AHO); aspartame was administered at 250 mg/kg once daily for 28 days followed by another 28-day daily administration of the plant extract at 200mg/kg. Both aspartame and plant extract were administered orally. Periodically, blood samples were collected for biochemical analyses and kidneys harvested for histopathological examination. Results: The biochemical parameters of renal insufficiency were significantly pronounced in the Asp group but not in the AHO. Oxidative stress was pronounced in the Asp and ALO but not in group AHO at day 57. Histopathological examination of the kidney obtained from the Aspartame group revealed destruction of glomeruli. Chronic administration of aspartame in rat caused sustained renal insufficiency which was ameliorated by prolonged administration of high dose of Ocimum gratissimum extract. Thus O. gratissimum extract is beneficial to aspartame induced renal toxicity in a dose dependent manner.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
阿斯巴甜、慢性肾功能不全和欧加木提取物
目的成对的人体肾脏是腹膜后器官,负责维持人体的内分泌。慢性肾病是全球发病和死亡的主要原因。营养和生活方式是慢性肾病发病的两个主要因素。阿斯巴甜是一种非营养性甜味剂,在全球普遍消费。甘菊是一种天然生长的植物,具有一定的药用价值。本研究探讨了口服阿斯巴甜是否会诱发大鼠肾功能不全,以及O. gratissimum提取物的合理改善作用:研究使用了 50 只动物,分为四组。对照组(CN)饲料正常。阿斯巴甜组(Asp)连续28天每天摄入250毫克/千克阿斯巴甜。阿斯巴甜低剂量gratissimum提取物组(ALO)每天摄入250毫克/千克阿斯巴甜,持续28天,然后每天摄入100毫克/千克提取物,持续28天。阿斯巴甜高剂量组(AHO)的阿斯巴甜剂量为 250 毫克/千克,每天一次,持续 28 天,然后每天再服用一次 200 毫克/千克的植物提取物,持续 28 天。阿斯巴甜和植物提取物均口服给药。定期采集血液样本进行生化分析,并采集肾脏样本进行组织病理学检查:结果:阿斯巴甜组肾功能不全的生化指标明显高于阿斯巴甜组。在第 57 天,Asp 组和 ALO 组的氧化应激明显,而 AHO 组则不明显。对阿斯巴甜组大鼠肾脏的组织病理学检查显示,肾小球遭到了破坏。长期服用阿斯巴甜会导致大鼠出现持续性肾功能不全,而长期服用大剂量的欧车前提取物则可改善这种状况。因此,O. gratissimum提取物对阿斯巴甜引起的肾毒性有益,其作用与剂量有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Evaluating Compliance and Performance of 0.5 mL AD Syringes: A Global Standards Review Acute Toxicity, Antioxidant and Vasodilatory Properties of Sclerocarya birrea (A. rich.) Hochst (Anacardiaceae) Trunk Bark’s Aqueous Decoction Towards Effective Healthcare Delivery: An Assessment of Public Perception of Pharmacist’s Role in Nigeria Multiple Drug Resistance in Burn Patients In-Process Quality Checks and Post-Market Surveillance of Artemether-Lumefantrine Fixed-dose Combination Tablets and Suspensions: Current Procedures, Successes, Advances, and Challenges
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1